ClinicalTrials.govpublic full text
Inobrodib, Pomalidomide and Dexamethasone Versus Standard Available Therapy in Relapsed or Refractory Multiple Myeloma
multiple myeloma refractory, multiple myeloma in relapse, inobrodib, pomalidomide, pomalyst, imnovid, dexamethasone, p300-cbp transcription factors, ccs1477, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 877111
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.